PRKCB and diabetes mellitus: Proof of this comes from observations that PKCβ inhibition with RBX enhances insulin action through phosphorylation of insulin- receptor substrate 1 (IRS1), Akt, eNOS, and GSK3α in STZ-DM and Zucker fatty insulin-resistant rats (73).